| dc.contributor.author | Malinauskienė, Vaidota | |
| dc.contributor.author | Zuzo, Anastasija | |
| dc.contributor.author | Liakina, Valentina | |
| dc.contributor.author | Kazėnaitė, Edita | |
| dc.contributor.author | Stundienė, Ieva | |
| dc.date.accessioned | 2023-12-22T07:05:50Z | |
| dc.date.available | 2023-12-22T07:05:50Z | |
| dc.date.issued | 2023 | |
| dc.identifier.issn | 2307-8960 | |
| dc.identifier.other | (WOS_ID)001048419800003 | |
| dc.identifier.uri | https://etalpykla.vilniustech.lt/xmlui/handle/123456789/153544 | |
| dc.description.abstract | Inflammatory bowel disease (IBD) is a chronic condition that affects young individuals in their reproductive years. It may have long-term implications on their reproductive, sexual, and mental health. IBD has been related to menstrual abnormalities. Furthermore, the administration of biological therapy can also result in gynecological issues in addition to the disease itself. The purpose of this review was to present potential menstrual cycle problems in patients with IBD, as well as the impact of adalimumab and other anti-tumor necrosis factor medications on gynecological pathology | eng |
| dc.format | PDF | |
| dc.format.extent | p. 4989-4995 | |
| dc.format.medium | tekstas / txt | |
| dc.language.iso | eng | |
| dc.relation.isreferencedby | Science Citation Index Expanded (Web of Science) | |
| dc.relation.isreferencedby | Scopus | |
| dc.relation.isreferencedby | PubMed | |
| dc.source.uri | https://www.wjgnet.com/2307-8960/full/v11/i21/4989.htm | |
| dc.title | Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology | |
| dc.type | Straipsnis Web of Science DB / Article in Web of Science DB | |
| dcterms.accessRights | This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/. | |
| dcterms.license | Creative Commons – Attribution – NonCommercial – 4.0 International | |
| dcterms.references | 33 | |
| dc.type.pubtype | S1 - Straipsnis Web of Science DB / Web of Science DB article | |
| dc.contributor.institution | Vilniaus universitetas | |
| dc.contributor.institution | Vilniaus universitetas Vilniaus Gedimino technikos universitetas | |
| dc.contributor.faculty | Fundamentinių mokslų fakultetas / Faculty of Fundamental Sciences | |
| dc.subject.researchfield | M 001 - Medicina / Medicine | |
| dc.subject.researchfield | N 004 - Biochemija / Biochemistry | |
| dc.subject.vgtuprioritizedfields | FM0202 - Ląstelių ir jų biologiškai aktyvių komponentų tyrimai / Investigations on cells and their biologically active components | |
| dc.subject.ltspecializations | L105 - Sveikatos technologijos ir biotechnologijos / Health technologies and biotechnologies | |
| dc.subject.en | menstrual disorders | |
| dc.subject.en | inflammatory bowel disease | |
| dc.subject.en | adalimumab | |
| dc.subject.en | infliximab | |
| dc.subject.en | anti-tumor necrosis factor-& alpha | |
| dcterms.sourcetitle | World journal of clinical cases | |
| dc.description.issue | iss. 21 | |
| dc.description.volume | vol. 11 | |
| dc.publisher.name | Baishideng Publishing Group Inc. | |
| dc.publisher.city | Pleasanton | |
| dc.identifier.doi | 001048419800003 | |
| dc.identifier.doi | 151666125 | |
| dc.identifier.doi | 37583859 | |
| dc.identifier.doi | 10.12998/wjcc.v11.i21.4989 | |
| dc.identifier.elaba | 175406231 | |
